PEPTONIC MEDICAL Cash Flow-to-Debt Ratio
PEPTONIC MEDICAL cash flow-to-debt ratio. PEPTONIC MEDICAL (28L) has a Cash Flow-to-Debt Ratio of -0.47x as of March 2026, meaning its operating cash flow of €-5.48 Million could theoretically repay 0% of its total liabilities (€11.59 Million) in one year. See financial flexibility index of PEPTONIC MEDICAL to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of PEPTONIC MEDICAL (2021–2025)
Cash flow-to-debt ratio of PEPTONIC MEDICAL from 2021 to 2025. Historical debt coverage capacity for PEPTONIC MEDICAL across 5 annual periods. Also explore PEPTONIC MEDICAL net asset momentum to track the company's year-over-year net asset growth rate.
PEPTONIC MEDICAL Cash Flow-to-Debt Ratio by Year (2021–2025)
PEPTONIC MEDICAL cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for PEPTONIC MEDICAL. For the full cash flow conversion analysis, see PEPTONIC MEDICAL (28L) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.74x | €-20.50 Million | €27.67 Million | ▲ +56.6% |
| 2024 | -1.71x | €-37.55 Million | €22.01 Million | ▼ -58.5% |
| 2023 | -1.08x | €-33.81 Million | €31.41 Million | ▼ -3.5% |
| 2022 | -1.04x | €-40.22 Million | €38.66 Million | ▲ +18.8% |
| 2021 | -1.28x | €-40.34 Million | €31.48 Million | — |